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Little attention has been given to how microRNA expression is aﬀected by environmental contaminants exposure. We investigate
the eﬀects of paternal exposure to benzo[a]pyrene (B[a]P) on miRNA expression in the developing mouse embryo. Male mice
w e r ee x p o s e dt oB [ a ] P( 1 5 0m g / k gi . p . ) ,a n dt h e i rs p e r mw a su s e df o u rd a y sl a t e ri nin-vitro fertilization experiments. Twenty
embryos each from 2-, 8-cell and the blastocyst stage were used for genome-wide miRNA expression proﬁling. Paternal exposure
to B[a]P aﬀected the expression of several miRNAs, and the target genes for some of the dysregulated miRNAs were enriched in
many diﬀerent pathways that are likely to be relevant for the developing mouse embryo. By linking the miRNA target genes to
publicly available databases, we identiﬁed some miRNA target genes that may serve as global markers of B[a]P-mediated genotoxic
stress. The dysregulated miRNAs may provide valuable knowledge about potential transgenerational eﬀects of sublethal exposure
to chemicals.
1.Introduction
Reduced sperm count and sperm quality are reported from
many developed economies [1] and there are also increased
rates of testicular cancer manifested in Western and North-
ern Europe [2, 3], Australia, and Northern America [4]. It
has been suggested that this negative development could be
caused by increased exposure to environmental contami-
nants. Physical as well as chemical exposures have been as-
sociated with reduced sperm quality in association studies
[5–10].
Chemical environmental contaminants have been shown
to negatively aﬀect reproduction and embryo development
in animals [11–15]. In humans, spermatozoa from infertile
men demonstrate higher levels of DNA damage compared to
fertile men, and sperm DNA damage is associated with low
sperm quality [16–19] and reduced fertility [20]. Concern
is being raised over the possibility that paternal germ
cell DNA damage in humans, induced by environmental
contaminants, could have an impact on the next generation.
Benzo[a]pyrene B[a]P is a carcinogenic contaminant
with ubiquitous distribution and potential reprotoxic eﬀects
[21–25]. B[a]P is found in coal tar, in automobile exhaust
fumes (especially from diesel engines), in all smoke resulting
fromthecombustionoforganicmaterial(including cigarette
smoke), and in charbroiled food. This compound is the
chemical compound whose ability to form DNA adducts has
been best characterized. B[a]P undergoes metabolic trans-
formation to a diol-epoxide, BDPE, in the human organism
[26, 27]. The global distribution and DNA damage-inducing
properties of B[a]P make it a relevant genotoxic model com-
pound for the study of potential transgenerational eﬀects of
paternal exposure.
MicroRNAs (miRNAs), discovered in 1993, are short
(17–25nucleotides)noncodingRNAswhichnegativelyregu-
late speciﬁc target genes by mRNA degradation or transla-
tional repression [28]. miRNAs have fundamental roles in
multiple cellular processes and are also implicated in the
development of multiple diseases (for a review see [29]).
Their importance is evident from phenotypes of knockout
and mutant mice and from studies comparing expression
proﬁles. Representing promising therapeutic targets and
candidate biomarkers in pathophysiology, miRNAs are an
active area of research. Several studies implicate miRNAs in2 International Journal of Cell Biology
the control of early embryonic development and mainte-
nance of the pluripotent stem cell state [30], but the impact
of environmental contaminants on miRNA expression has
been little studied so far. Recently, epigenetic mechanisms
through which paternal inﬂuence on oﬀspring development
have received more attention [31], and miRNAs play a key
role in epigenetic regulation.
Following paternal acute exposure to B[a]P four days
prior to fertilization, we studied the global miRNA expres-
sion proﬁle of the developing mouse embryo. We demon-
strate that genome-wide miRNA expression proﬁling studies
can be performed on a very limited number of cells and that
earlyembryonictranscriptionofmultiplemiRNAsisaﬀected
byB[a]Pexposureofthefertilizingsperm.Toourknowledge,
this is the ﬁrst report on embryonic miRNA modulation, fol-
lowing paternal exposure to environmental contaminants.
2. Methods
2.1.TheExposureofMaleMicefromwhichSpermW asDerived
for IVF. Exposed males (strain B6D2F1 from Charles River
Laboratories, 8–12 weeks of age) received one i.p. injection
of B[a]P (150mg/kg body weight) dissolved in corn oil four
days prior to the IVF experiment. Timing of the exposure
to B[a]P was based on pilot studies and knowledge about
the most susceptible stage of spermatogenesis with respect to
dominant lethal mutations. Similarly, aged control males re-
ceived an equivalent volume of corn oil. At the day of the
IVF experiment, males were killed by cervical dislocation.
Cauda was surgically removed and collected in an eppendorf
tubecontainingM2medium(500μL,Sigma).Usingapairof
microscissors,afewincisionsweremadeinthecaudaandthe
sperm was allowed to disperse for 10 minutes in a small drop
(250μL) of HTF medium (EmbryoMax, Millipore) under
liquid paraﬃn (MediCult) before transfer to the IVF dishes.
Experiments are based on oocytes from 36 females and spe-
rm from 6 males (3 exposed and 3 controls) altogether.
2.2. Superovulation and In-Vitro Fertilization (IVF). Females
(strain B6D2F1 from Charles River Laboratories, 4–6 weeks
ofage)wereinjectedi.p.withpregnantmareserumhormone
gonadotropine (PMSG, Folligon from Intervet) (5IU) three
days prior to the IVF procedure. Two days later (i.e., the day
before the IVF) animals received an additional i.p. injection
of human chorionic gonadotropine (HCG, Ovitrelle from
Serono) (5IU). Mice were killed by cervical dislocation and
oviducts were collected in M2 medium (Sigma). Egg clutches
(10–20 oocytes) embedded in cumulus cells were extracted
from each oviduct. Oocytes were transferred to IVFdishes
andincubatedinadropletofHTFspermcontainingmedium
under liquid paraﬃnf o r4 . 5 h( 3 7 ◦C). Oocytes from one
side of the animal were combined with sperm from B[a]P
exposedanimalsandoocytesfromtheothersidewherecom-
binedwithspermfromcontrolanimals.Hence,oocytesfrom
all animals were present in both the control group and the
exposed group. After 4.5h, the fertilized oocytes (zygotes)
were washed 5X in KSOM medium (EmbryoMax Millipore)
before they were transferred to a drop of KSOM (200μL)
in a petri dish (35mm) under liquid paraﬃn (MediCult).
The zygotes were allowed to grow for harvesting at the 2-
cell, 8-cell and blastocyst stage. At harvest, 20 embryos were
collected in microtubes ﬁlled with 5μL lysis medium (Cellu-
Lyser, TATAA) and then frozen at −80◦C until use. Hence,
the 20 embryos contained in one sample represent a random
selection of fertilized oocytes from 12 diﬀerent females, all
of which had been fertilized by the same male. There are no
technical replicates; values are based on one pooled sample
of 20 biological replicates at each stage and treatment.
2.3. Genome-Wide miRNA Expression Proﬁling. Embryo ly-
sates were subjected to global miRNA preampliﬁcation using
SBI small RNA ampliﬁcation kit according to manufacture’s
protocol (System Biosciences (SBI), Mountain View, CA).
The Small RNA ampliﬁcation system consists of three steps:
(1)ligationofanadaptertothe3  endoftheRNA,(2)reverse
transcription of the RNA and attachment of a 5 -end adapter
in the same reaction by template switching, and (3) PCR
ampliﬁcation of the cDNA with a PCR polymerase mixture
that incorporates a proof reading function. Brief descrip-
tion of the protocol: in the adapter ligation step RNase-free
water (2μL), SBI ligase buﬀer (5μL), SBI 3  adaptor (0.5μL),
total RNA from lysed samples (5μL), and SBI ligase cocktail
(0.5μL) were mixed and incubated (1 hour, 37◦C). In the
ﬁrst strand synthesis RNase-free water (4μL), SBI 3  adaptor
primer (0.5μL) and ligation product from the adaptor liga-
tion (1μL) were mixed and incubated in two steps (1 minute
at 65◦C followed by 5min at 42◦C). In the reverse transcrip-
tase step, a mastermix consisting of SBI 5X reverse trans-
criptase buﬀer (2μL), SBI dNTP mix (1μL), SBI 5  adaptor
(0.5μL), SBI dithiothreitol (0.5μL), and SBI reverse tran-
scriptase (0.5μL) were mixed with the preceding ﬁrst-strand
synthesisproductandallowedtoincubateintwosteps(5min
at 42◦C, and then 10min at 95◦C). Reactions were then kept
oniceuntilsecond-strandsynthesisandampliﬁcation.Inthe
second strand synthesis and ampliﬁcation step, the product
from the ﬁrst strand cDNA synthesis step was mixed with
RNase-free water (77μL), SBI 10X PCR buﬀer (10μL), SBI
dNTPmix(2μL),SBI3 adaptorprimer(4μL),SBI5 adaptor
primer(4μL),andSBIPCRpolymerase(3μL).Thereactions
were transferred to a thermal cycler (Eppendorf mastercy-
cler) and underwent the following program: 5min at 95◦C,
42times(25secat95◦C,20secat55◦C,30secat72◦C),30sec
at 72◦C, and held at 15◦C.
2.4. Real-Time qPCR Reaction. Following miRNA ampliﬁca-
tion, genome-wide qPCR miRNA expression proﬁling was
performed using mouse miRome microRNA qPCR Proﬁler
from System Biosciences, which simultaneously proﬁles all
knownmousemiRNAs,onanAppliedBiosystems7500Real-
time PCR system (Applied Biosystems, Foster City, CA). The
miRNA proﬁling was performed by qPCR using microRNA-
speciﬁc primers and SYBR Green RT2 ROX mastermix (Qia-
g e n ,G e r m a n y ) .I nb r i e f ,e a c h2 0μL qPCR reaction included
SYBR Green RT2 ROX master mix buﬀer (10μL), SBI
universalreverseprimer(0.10μL),globallyampliﬁedmiRNA
samples (0.13μL), SBI Quantimir microRNA primer (4μL),
andRNase-freewater(5.75μL).ThePCRprogramwas2min
at 50◦C, 10min at 95◦C, 40 times (15sec at 95◦C, 1min atInternational Journal of Cell Biology 3
60◦C,35secat72◦C(dataread)),followedbyameltingcurve
analysis step.
2.5. Data Analysis. Raw CT-values from 457 miRNAs were
preprocessedtoremoveoutliersandmiRNAsforwhichthere
were inadequate measurements. The CT values equal to 35
cycles were considered as a limit of detection and all CT val-
ues > 35 were removed from downstream analysis. In addi-
tion, ﬁltering criterium for missing values was set to 80%,
which is the minimum percentage of existing values, and all
thepatternswithlessthan80%existingvalueswereremoved.
Only those miRNAs passing quality assurance criteria were
included in the downstream analysis. Missing values were
imputed by average nonmissing values of that particular
sample.
The raw CT-values were normalized using the mean ex-
pressionvalueofallexpressedmiRNAsaspreviously[32,33],
and the mean expression value for individual sample was
calculated from miRNAs with CT-values ≤ 35 cycles. The
relative expression levels in samples were analyzed by the
comparative CT-method [34, 35]. The fold change indicates
the expression level of miRNAs from paternal B[a]P exposed
samples relative to that of untreated control samples. The
miRNA expression levels are hence always relative to the un-
treated control sample. The fold change values were log2-
transformed in order to make the data symmetrical around
zero. Unsupervised hierarchical clustering analysis was per-
formed to cluster variables into groups based on their
similarity, and the results were visualized in a dendrogram
using MeV v4.7 software [36] or J-Express v2009 (MolMine,
Bergen, Norway) [37]. The miRWalk database was used to
identify potential miRNA target genes [38]. The miRWalk
algorithm is based on a computational approach which
identiﬁes the longest consecutive complementary between
an miRNA and a gene sequences; miRWalk compares the
gene’s identiﬁed miRNA binding sites with the results of
eight established miRNA-target prediction programs. The
miRWalk database can provide miRNA targets interaction
information produced by eight diﬀerent established miRNAs
prediction programs.
For functional enrichment analysis of the miRWalk pre-
dicted target genes, we used the WebGestalt V2 [39]. The
WebGestalt V2 is a web-based gene set analysis tool, and it is
a suite of tools for functional enrichment analysis in various
biological contexts. WebGestalt compares a user-upload-
ed gene list with genes in predeﬁned functional categories
to identify those categories with enriched numbers of user-
uploaded genes. The WebGestalt V2 enrichments analysis is
based on hypergeometric statistical tests, including Benja-
mini and Hochberg multiple test adjustment. The minimum
number of genes per category was set to 2 (default), and the
whole mouse genome was used as reference gene set. The
enrichment analysis identiﬁed the top 10 pathways with the
most signiﬁcant P-values.
3. Results
Zygotes and embryos from three preimplantation stages (2-
and8-cellaswellastheblastocyststage),fertilizedeitherwith
control sperm or with sperm from B[a]P-treated mice, were
used to study the eﬀect of paternal exposure to B[a]P on the
expression of a panel of 456 mouse miRNAs.
A total of 60 in-vitro fertilized embryos (30 derived from
B[a]P exposed sperm and 30 from control sperm) at three
diﬀerent developmental stages were used for the ﬁnal ana-
lysis. We timed our sample extraction according to 24h cyc-
les, with the 2-, 8-cell, and blastocyst time points referring to
24h, 72h, and 120h, respectively. The stages can be readily
identiﬁed up to the 8-cell stage with careful visual inspection
servingasadditionalqualitycriteriauponsampling.Samples
were selected exclusively from the pool of healthy looking
embryos representative of that particular stage. It is well
known that embryonic cell cycle duration is subject to con-
siderable variation, not only among diﬀerent embryos, but
also among blastomeres within the same embryo [40–42].
3.1. miRNA Expression Proﬁling. Figure 1 shows a Venn-dia-
gram of the number of miRNAs expressed at diﬀerent stages.
Some diﬀerences were noted in the number of miRNAs ex-
pressed at diﬀerent stages among control embryos and emb-
ryos of B[a]P exposed fathers; more miRNAs were expressed
in the exposed group at the 2-cell and the blastocyst stage
than in controls. At the 8-cell stage, there were more
miRNAs expressed in the control group than in the exposed
group. The Venn-diagram in Figure 1 also reveals that more
miRNAs were expressed consistently across all stages among
embryos of B[a]P exposed fathers compared to controls.
The outcome of the quality assurance ﬁltering criteria
mentioned above was a set of 102 miRNAs, and these miR-
NAs were used in the downstream analysis. Unsupervised
hierarchical clustering analysis of these 102 miRNAs was
performed using MeV v4.7 software [36], and the resulting
heatmap is presented in Figure 2. By visual inspection of the
heatmap, we observed that the 8-cell and blastocyst embryos
were clustered close to each other and shared similar expres-
sionpatterncomparedtothe2-cellembryo(Figure 2).There
were also some miRNAs which were predominantly up- or
downregulatedfollowingpaternalB[a]Pexposureinallthree
stages. From these dysregulated miRNAs, we selected six
miRNAs from the upregulated part and six from the down-
regulated part of the spectrum for target-genes analysis
(Figure 2). We were primarily interested in B[a]P-induced
eﬀects, and therefore we consistently selected the up- or
downregulated miRNAs across all stages. The six up- and six
downregulated miRNAs selected are shown in Table 1.
We then used the miRWalk database [38]i no r d e rt o
identify potential miRNA targets for the selected B[a]P dys-
regulatedmiRNAs.Theintersectionofidentiﬁedtargetgenes
from at least ﬁve prediction programs was chosen, and the
numbers of predicted target genes for each selected miRNA
are shown in Table 1.
Each miRNA can regulate numerous target genes and
therefore has the potential to alter multiple biochemical
pathways. To investigate what pathways may be regulated
by our twelve selected dysregulated miRNAs, we evaluated
the biological functions of their predicted target genes using
WebGestalt V2 [39]. We correlated predicted target genes
withtheKEGG(KyotoEncyclopediaofGenesandGenomes)4 International Journal of Cell Biology
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Figure 1: Venn-diagram showing number of samples at the
three diﬀerent developmental stages among control embryos and
embryos of B[a]P exposed fathers, respectively.
biochemical pathways [43] in order to identify enriched
pathways. The results from enrichment analysis represent
a global picture of pathways that are signiﬁcantly enriched
with target genes for dysregulated miRNAs following pater-
nal B[a]P exposure.
Signiﬁcantly enriched KEGG pathways annotating the
predicted target genes for the twelve dysregulated miRNAs
following paternal B[a]P exposure are presented in Table 2.
The complete set of signiﬁcantly enriched pathways annotat-
ing target genes are listed in Supplementary Table 1 (see Sup-
plementary Material available at doi:10.1155/2012/407431).
Examples of some signiﬁcantly enriched pathways are cyto-
kine-cytokine receptor interaction, insulin signaling path-
way, regulation of actin cytoskeleton, apoptosis, and MAPK
signaling pathway; these are shown in Table 2. The identiﬁed
pathways are enriched mainly with target gene sets for the
six upregulated miRNAs following paternal B[a]P exposure.
KEGG pathways signiﬁcantly enriched in target gene sets for
the six downregulated miRNAs are involved in cell cycle,
neuroactive ligand-receptor interaction, TGF-beta signaling
pathway, calcium signaling pathway and chemokine signal-
ing pathway (Table 2). Some pathways were enriched in both
the up- and the downregulated target genes.
3.2. In-Silico Analysis of the Predicted Target Genes for the
Twelve Dysregulated miRNAs. We wanted to investigate how
the expression pattern of our target genes are modulated in
other reported systems in which B[a]P-induced gene expres-
sion modulations has been studied. To this end, we per-
formed a search in the publicly available gene expression
databases, such as NCBI Gene Expression Omnibus (GEO)
[44] and ArrayExpress [45]. Here, we wanted to identify
genes from our target gene list that have been modulated
by B[a]P exposure to male mice in other systems and at the
same time see if the expression pattern of these genes anti-
correlate with the expression pattern of the twelve dysreg-
ulated miRNAs in our study. Since mRNA expression proﬁl-
ing data from experiments similar to our study are not avail-
able,weusedthemicroarraygeneexpressiondatafromVerh-
ofstad and coworkers [46], represensting a study of gene
expression analysis in mice testis following one acute B[a]P
exposure (13mg/kg bw) by oral gavage [46]. Spermatogene-
sis takes place in testis, and comparing gene expression pat-
terns between the two types of experiments might be useful.
Verhofstad and coworkers studied B[a]P exposure-induced
changes in gene expression patterns in testis in both wild-
type and Xpc-knockout mice. In order to compare our target
gene list with the testis gene expression microarray data, we
downloaded the raw microarray data (GEO accession num-
ber: GSE17979) deposited in the GEO database [44]. These
microarray data (the gpr-ﬁle: GenePix Results ﬁle) were
reanalyzed as described previously [47]; all data processing
was performed in J-Express v2009 [37]. Only the micro-
array data from wild-type mice exposed with B[a]P and
untreated controls were used for reanalysis. The log2-trans-
formed ratios of the processed intensities were further
analyzed by SAM (Signiﬁcance Analysis of Microarray) [48].
SAManalysiswasconductedinordertoidentifygeneswhose
meanexpressionlevelissigniﬁcantlydiﬀerentbetweenB[a]P
exposed and untreated control samples. This resulted in 345
genes identiﬁed as signiﬁcantly diﬀerentially expressed (FDR
< 10%). We then conducted similarity searches between our
target gene list and SAM-identiﬁed gene list; this process
identiﬁed 63 genes which showed anticorrelated expression
pattern to our dysregulated twelve miRNAs. Of those genes,
44 were downregulated and 19 were upregulated in mice
testis following B[a]P-exposure. Figure 3 shows hierarchical
clustering analysis of these 63 genes. By visual inspection
of the heatmap (Figure 3), we observed that B[a]P-exposed
samples clustered close to each other in one branch whileInternational Journal of Cell Biology 5
Figure 2:Unsupervisedhierarchicalclusteringanalysisoftherelativeexpressionof102miRNAsafterﬁlteringandnormalizationofthedata.
The hierarchical clustering analysis is based on similarities in gene expression. Red samples represent upregulated miRNAs whereas green
samples represent downregulated miRNAs. The blue color code represents six upregulated miRNAs, and the purple color code represents six
downregulated miRNAs, which were selected for further analysis.
untreated control samples clustered in the other branch. The
gene expression proﬁles constituted by these altered genes
along with their anticorrelated miRNA can be used as a basis
for identiﬁcation of B[a]P-exposure gene expression signa-
tures. Using the results of both miRNA and mRNA expres-
sion proﬁling—in combination with what is known about
miRNA functions—we expect that identiﬁcation of anticor-
related miRNA-mRNA pairs will narrow down the target
gene list and reﬁne the predicted miRNA-mRNA interac-
tions.
We also compared our twelve most dysregulated genes
with the miRz miRNA expression database [49]. The result
of this comparison is expressed in Supplementary Figure 1.
It appears, based on the miRz database, that some of
the twelve dysregulated miRNAs, most notably miR-210,
miR-294, and miRs-466f-5p are highly expressed in several6 International Journal of Cell Biology
Table 1: Expression levels of the six up- and down-regulated miRNAs in developing embryos derived from B[a]P exposed fathers, relative
to unexposed controls.
miRNA Direction 2-cell 8-cell Blastocyst # target genes(a)
mmu-miR-574-5p Up 2.73 2.00 1.91 531
mmu-miR-467f Up 5.83 1.23 2.23 972
mmu-miR-294 Up 3.22 1.74 1.19 646
mmu-miR-210 Up 2.27 1.26 2.48 127
mmu-miR-197 Up 1.91 2.41 1.80 379
mmu-miR-139-3p Up 4.33 2.56 1.93 333
mmu-miR-99a Down −1.29 −2.56 −0.56 64
mmu-miR-483 Down −0.39 −1.23 −13.45 107
mmu-miR-466f-5p Down −4.40 −2.86 −2.08 318
mmu-miR-346 Down −4.16 −2.04 −0.32 453
mmu-miR-1906 Down −4.63 −1.38 −1.03 615
mmu-miR-1896 Down −6.18 −4.94 −3.06 638
Note: Log2-transformed ratio of B[a]P and control; (a)predicted targets.
Table 2: Number of targets genes in enriched KEGG pathways for the six up-regulated and the six down-regulated genes.
(a) Six upregulated miRNAs
Enriched KEGG pathways
Selected dysregulated miRNAs
mmu-miR-
139-3p
mmu-miR-
197
mmu-miR-
210
mmu-miR-
294
mmu-miR-
467f
mmu-miR-
574-5p
Metabolic pathways 37 27 8 32 47 28
Cytokine-cytokine receptor interaction 7 11 23
Insulin signaling pathway 9 14 11
Pathways in cancer 16 22 15
Regulation of actin cytoskeleton 6 16 13
Apoptosis 4 8
MAPK signaling pathway 16 13
Pancreatic cancer 2 8
(b) Six downregulated miRNAs
Enriched KEGG pathways
Selected dysregulated miRNAs
mmu-miR-
1896
mmu-miR-
1906
mmu-miR-
346
mmu-miR-
466f-5p
mmu-miR-
483
mmu-miR-
99a
Metabolic pathways 54 40 23 7 7 7
Pathways in cancer 14 10 4 2
Cell cycle 322
Neuroactive ligand-receptor
interaction 13 9 5
TGF-beta signaling pathway 6 3 2
Calcium signaling pathway 12 11
Chemokine signaling pathway 11 2
Glycerophospholipid metabolism 7 3
Leukocyte transendothelial migration 8 9
Melanogenesis 32
Progesterone-mediated oocyte
maturation 52
Note: number of target genes for particular miRNA that are enriched in particular KEGG pathway.International Journal of Cell Biology 7
Figure 3: Heatmap showing the result of unsupervised hierarchical clustering of genes from previously published B[a]P sensitive testis
dataset (63 genes), targeted by the 12 dysregulated miRNAs identiﬁed in the present report. Vertical blue color bar indicates target genes
(n = 19) for the six upregulated miRNAs, and the green bar indicates target genes (n = 44) from downregulated target miRNAs. Average
fold change in gene expression is indicated in the far right column. Some of the genes are targeted by more than one miRNA.
tissues, whereas others (miR-139-3p, miR-197, miR-1896,
miR-346, and miR-1906) have not been detected.
4. Discussion
The most important ﬁnding from this work is that multiple
miRNAs are diﬀerently expressed in embryos of B[a]P
exposed fathers relative to control embryos. Our results also
demonstrate that miRNAs expression can be measured in
veryfewcells.Thefunctionalimplicationsofearlyxenobiotic
induced suppressed or enhanced single miRNA expression
proﬁles in developing embryos are not well understood;
however, given the broad array of gene transcripts targeted
by miRNAs, the perturbations are likely, at some level, to be
detrimental to the development of the embryo.
Thehighlydynamicphysiologyofthedevelopingembryo
is reﬂected in dynamic miRNA expression proﬁles. Mater-
nally inherited miRNAs are abundant in the mouse zygote,
but many of the maternal gene products are quickly down-
regulated during the maternal-zygotic transition; some are
downregulated by as much as 95% between the 1- and 2-
cell stages [50]. A 60% decrease in miRNA expression levels
has been reported, indicating that miRNAs may be degraded
similar to maternal mRNAs [51]. Transcription of zygotic
RNAs begins at the 2-cell stage [52], and ∼2.2-fold increases
in miRNA expression have been noted from the 2- to 4-cell
stage [51]. In the cluster analysis (Figure 2), the 8-cell stage
andtheblastocyststageclustertogether,indicatingthatthe2-
cell stage exhibited a somewhat diﬀerent expression proﬁle
from the two other stages. The maternal-zygotic transition8 International Journal of Cell Biology
may represent a particularly sensitive stage of embryonic
development.
The predicted target genes for miRNAs that were found
to be dysregulated in the present study by paternal B[a]P
exposure participate in numerous biochemical pathways.
Among the enriched KEGG pathways were those related to
metabolism, cancer, cell cycle, apoptosis, MAPK signaling,
cytokine-cytokine receptor interaction, and TGF-beta sig-
naling (Table 2 and Supplementary Table 1). The predicted
genes aﬀected by the B[a]P-induced miRNA aberrations
overlap with previously published B[a]P-sensitive testis gene
dataset; the resulting genes are shown in Figure 3. We did not
have any information available on embryonic expression of
miRNA target genes in our current study. The testis dataset
from Verhofstad represents the closest match we could ﬁnd
in the literature, but it is not known to what extent gene
expression in the B[a]P exposed developing embryos would
match the testis gene expression of B[a]P exposed mice; we
are pursuing this question.
Perhaps the most interesting miRNA for embryonic dev-
elopment is mmu-miR-294, a member of the miR-290 clus-
ter. In mouse embryonic stem cells (ES) miR-294 has been
shown to promote pluripotency by regulating a subset of c-
Myc target genes and upregulating pluripotency-associated
genes such as Lin28 [30]. It has been estimated that the miR-
290 cluster alone makes up greater than 70% of the total
quantity of miRNAs in ES [53]. Expression of this cluster
is rapidly downregulated upon diﬀerentiation, coincident
with an elongation of the cell cycle. The miR-290 cluster
maintains a very short cell cycle in ES by suppressing the
G1/S restriction. A similar suppressed G1/S restriction is ob-
served in cancer cells [54], and it is interesting to note that
miR-106b promotes cell cycle progression in a breast cancer
cell line [55], by mechanisms similar to the miR-290 cluster
in ES, indicating similarities in the molecular control of
the cell cycle of embryonic and cancer cells [56]. In our
analysis, the predicted target genes for mmu-miR-294 were
enriched in pathways related to MAPK-signaling, apoptosis,
and cancer. A recent report found that the miRNAs-290
cluster was more abundantly expressed in the inner cell mass
than in the trophectoderm of the blastocyst, and the authors
suggest that this asymmetric pattern of stemness-controlling
miRNA expression contributes to cell specialization [57].
Another gene found to be downregulated in developing
embryos following paternal B[a]P exposure was mmu-miR-
210. Controlling of the mitochondrial metabolism during
hypoxia has been shown to involve miR-210, which is readily
and dynamically aﬀected by hypoxia inducible factor 1 (HIF-
1α), the master regulator of the hypoxic response [58]. The
cell cycle regulator E2F3 [59], the receptor tyrosine kinase
ligand ephrin A3 [60], and the DNA repair protein RAD52
[61] have all been studied as targets for repression by miR-
210. The iron-sulfur cluster assembly proteins ISCU1 and
ISCU2 have been identiﬁed as direct targets for miR-210
in human lung endothelial cells [62]. Besides mitochon-
drial metabolism, the miR-210 may also be involved in
other hypoxia-dependent processes such as iron metabolism,
which is controlled by ISCU1/2 activity [63]. Furthermore,
hypoxic repression of mitochondrial function by miR-210
and ISCU1/2 could theoretically trigger mitophagy—a form
ofautophagyinwihichdefectivemitochondriaareselectively
delivered to lysosomes for degradation. Mitophagy has been
characterized as a-HIF-dependent mechanisms [64], but it
remains to see if miR-210 itself induces mitophagy.
Amongthegenesthatweredownregulated,themostdra-
matic response was seen for mmu-miR-483. Aberrant ex-
pression of miR-483 has been reported in mice fed high-fat
diets[65]indicatingaroleofthismiRNAinenergymetaboli-
sm. Consistent with the identiﬁcation of miR-483-5p as an
intronic miRNA encoded within the second intron of the
Igf2 gene [66], a recent report conﬁrms coexpression of
miR-483-5pandinsulin-likegrowth-factor2(Igf2)[67].Igf2
has been primarily implicated in the regulation of prena-
tal growth [68], but mice carrying the Igf2 transgene have
also been shown to have reduced bodyfat [69], and reduced
Igf2expressioninadultshavebeenshowntobeaccompanied
by increased fat deposition [70] .I nt h e i rr e p o r t ,M aa n dc o -
workers found that overexpression of miR-483-5p lead to
a decrease rather than an increase in Igf2 mRNA and the
authors suggest that miR-483-5p regulates Igf2 expression
both by suppressing Socs3 and via an additional undiscov-
ered mechanism [67].
Another miRNA that was found to be downregulated in
embryosofB[a]Pexposed fathersrelative toembryosofcon-
trol fathers was miR-346. MiR-346 has been shown to
be involved in regulation of carcinogenesis, inﬂammatory
response, and diﬀerentiation [71–73]. Interestingly miR-346
has also been shown to target receptor-interacting protein
140 (RIP140) mRNA, and thereby upregulate its protein
expression without altering mRNA levels [74]. RIP140 is
a transcription coregulator that modulates the activities of
many nuclear receptors and transcription factors [75]. The
physiological function of RIP140 has been demonstrated in
a gene knockout animal model and cell-line based systems;
these include roles in gluoconeogenesis, glycolysis, fatty acid
oxidation, and mitochondria biogenesis as well as modula-
tion of hormone target genes [76–79]. The reduced expres-
sion of miR-346 observed in embryos of exposed fathers in
thepresentstudycouldindicatereducedRIP140transrepres-
sion of gene regulation.
A conservative evaluation of up- and downregulated
miRNAs in developing embryos is advisable due to the in-
herent complexity of these mechanisms. Still, the study of
gene and miRNA expression proﬁles in developing embryos
descending from exposed fathers, as exempliﬁed in this
report, could open up new avenues in our understanding
of sublethal transgenerational eﬀects of environmental expo-
sure. Previous experiments looking at miRNA expression in
developing embryos have pooled hundreds of mouse embry-
os [57]; here we demonstrate that miRNA expression proﬁles
can be obtained from very few embryos. This illustrates a
potential of similar experimental approaches in relation to
the REACH EU Directive (Registration, Evaluation, Authori-
zation and Restriction of Chemicals), implying that chem-
icals may be tested for eﬀects on fertility and development
using very few animals.International Journal of Cell Biology 9
Our study has some limitations with respect to biological
and technical replicates. Furthermore, mRNA expression
proﬁling of the target genes from in-vitro fertilized embryos
of B[a]P exposed fathers would have strengthened the ﬁnd-
ings. There may also be some incidences of false predictions,
amongtheidentiﬁedtargetgenes.Toreducethelikelihoodof
such errors, we narrowed and reﬁned the list of target genes
by comparing them with publically available gene expression
data.
In conclusion, preconceptional paternal exposure to
B[a]PmayaﬀectmiRNAexpressioninthedevelopingmouse
embryo. More research is needed to fully appreciate the im-
plications of early dysregulated miRNA expression, but given
the wide array of cellular processes targeted by miRNAs,
undesired consequences are expected. Gene and miRNAs
expressioninearlyembryosmayprovidevaluableknowledge
aboutpotentialtransgenerationaleﬀectofsublethalexposure
to exogenous compounds.
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